Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

Table 3

IK as response. 112 samples, positive : negative = 77 : 35.

Clinical endpoints	value	Values	MTBL positive	MTBL negative
Category	0.2246	Squamous cell carcinoma (SCC)	30	8
		Lung adenocarcinoma (LAC)	32	18
		Bronchioloalveolar carcinoma (BAC)	8	7
		Small cell lung carcinoma (SCLC)	7	2
Clinical stage	0.9386	I, II	33	16
		III, IV	44	19
Tumor size	1	≤3 cm	33	15
		>3 cm	44	20
Lymph node metastasis	0.4841	Yes	53	21
		No	24	14
Gender	0.1879	Male	36	11
		Female	41	24
Pathology grade	0.6250	I	14	7
		II	36	13
		III	27	15
Age	0.8946		60.00 (mean), 9.86 (sd)	60.26 (mean), 9.31 (sd)